- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05950620
Bringing Weight Management Into the Primary Care Pediatric Practice
July 17, 2023 updated by: Jonathan Purnell, Oregon Health and Science University
Pilot and Feasibility Project to Establish a Childhood Nutrition and Health Clinic Managing Weight and Obesity Complications in a Primary Care Pediatric Practice
This project aims to move what is currently a specialty-care model for the management of obesity of children and adolescents into the primary care setting.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The goal of this project is to create a sustainable clinical model in the primary care setting that improves nutritional health, lessens obesity, and addresses weight-related complications of children and adolescents to reduce risk for metabolic disease in later life.
The primary objectives include tracking changes in BMI (both absolute and percentile) and levels of hemoglobin A1c, liver enzymes (AST, ALT levels), and lipids in patients seen in a primary care setting by a general pediatrician board-certified in obesity medicine.
Secondary objectives include tracking patient adherence, follow-up, and retention.
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jonathan Q Purnell, MD
- Phone Number: 503-494-1056
- Email: purnellj@ohsu.edu
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Active, not recruiting
- Oregon Health & Science University
-
Portland, Oregon, United States, 97225
- Recruiting
- The Children's Clinic
-
Contact:
- Susanne Purnell
- Phone Number: 503-297-3371
- Email: spurnell@childrens-clinic.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients in a general pediatrician's office internally in Portland, Oregon.
Description
Inclusion Criteria:
Children with obesity (BMI > 30 kg/m2 or > 95th percentile) or in need of weight management of unwanted weight gain.
Exclusion Criteria:
None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intervention
Pediatric patients with obesity or in need of weight management for unwanted weight gain.
|
Dietician visits, education, anti-obesity medications, and/or referral for metabolic-bariatric surgery as indicated by American Academy of Pediatrics guidelines for obesity management.
|
|
Controls
Historic controls matched to the Intervention group on age, sex, and BMI percentile.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in body weight
Time Frame: Baseline to follow-up (1-3 years)
|
Body weight in kg
|
Baseline to follow-up (1-3 years)
|
|
Change in body height
Time Frame: Baseline to follow-up (1-3 years)
|
Body height in meters
|
Baseline to follow-up (1-3 years)
|
|
Change in BMI
Time Frame: Baseline to follow-up (1-3 years)
|
BMI will be calculated using the formula: kg weight / m2 height.
Will be in both absolute and percentile for age
|
Baseline to follow-up (1-3 years)
|
|
Impact on glucose control
Time Frame: Baseline to follow-up (1-3 years)
|
Hemoglobin A1c levels
|
Baseline to follow-up (1-3 years)
|
|
Impact on fatty liver
Time Frame: Baseline to follow-up (1-3 years)
|
Levels of liver enzymes ALT, AST
|
Baseline to follow-up (1-3 years)
|
|
Impact on lipid levels
Time Frame: Baseline to follow-up (1-3 years)
|
Levels of total, LDL, HDL, and non-HDL cholesterol.
Triglycerides.
|
Baseline to follow-up (1-3 years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient follow-up metrics
Time Frame: Baseline to follow-up (1-3 years)
|
Patient clinical follow-up rate, medication adherence, and retention
|
Baseline to follow-up (1-3 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
July 11, 2023
First Submitted That Met QC Criteria
July 11, 2023
First Posted (Actual)
July 18, 2023
Study Record Updates
Last Update Posted (Actual)
July 19, 2023
Last Update Submitted That Met QC Criteria
July 17, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB 24927
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
This study uses anonymized data.
No IPD will be generated.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Childhood
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on Medical obesity management.
-
University of BristolCompletedChildhood ObesityUnited Kingdom
-
University of AlbertaAlberta Innovates Health SolutionsCompleted
-
Ji Xunming,MD,PhDUnknown
-
Postgraduate Institute of Medical Education and...CompletedObesity | Diabetes MellitusIndia
-
Northwestern UniversityUniversity of Chicago; Endeavor HealthRecruitingBenign Prostatic HyperplasiaUnited States
-
Adana City Training and Research HospitalCompletedObesity | Binge-Eating Disorder | Weight Loss | Group MeetingsTurkey
-
Children's Hospital Medical Center, CincinnatiChildren's Hospital ColoradoActive, not recruitingDiabetes Mellitus, Type 2 | Pediatric Obesity | Bariatric Surgery CandidateUnited States
-
Avanos MedicalCompletedSacroiliac Joint PainUnited States
-
J. MoccoUniversity at Buffalo; MOUNT SINAI HOSPITALCompletedIntracranial HemorrhageUnited States
-
Université de SherbrookeCanadian Institutes of Health Research (CIHR)Active, not recruiting